The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds
Even getting off the couch takes planning
Physiologically, ROS participate in cyclic endometrial remodeling, hormone signal transduction, decidualization, and embryo implantation [1, 9]
MAX DENNING: You need a huge number of doctors, you need a huge number of sites to be participating in the clinical trials to get all of that data and make sure that this is a safe and effective medication
For patients seeking GLP-1s, this difference can be important, Ramachandran said
Who couldnt use a little extra push